Drug Pipeline

Efimosfermin alfa Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
4
Recruiting
2
Phase 3
1
Top Sponsors
Active Studies by Phase
Phase 3
2
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07221188 A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa… Non-alcoholic Fatty Liver Disease Recruiting
NCT07221227 A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With… Non-alcoholic Fatty Liver Disease Recruiting
Phase 1
NCT07335198 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of… Non-alcoholic Fatty Liver Disease Recruiting
NCT07358546 A Study of Efimosfermin Alfa in Adults With Hepatic Impairment Non-alcoholic Fatty Liver Disease Recruiting
Sponsors Running Efimosfermin alfa Trials
GlaxoSmithKline (4)
Get alerts when Efimosfermin alfa trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free